Free Trial
→ Trump wipes out trillions overnight… (From Porter & Company) (Ad) Buy CIM Stock  Free CIM Stock Alerts

Chimera Investment (CIM) Financials

Chimera Investment logo
$12.98 -0.10 (-0.73%)
Closing price 03:59 PM Eastern
Extended Trading
$13.26 +0.29 (+2.24%)
As of 06:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare
Annual Income Statements for Chimera Investment

Annual Income Statements for Chimera Investment

This table shows Chimera Investment's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Net Income / (Loss) Attributable to Common Shareholders		 90 52 -587 596 15 341 368 491 549 250 589
Consolidated Net Income / (Loss)		 176 126 -513 670 89 414 412 525 552 250 589
Net Income / (Loss) Continuing Operations		 176 126 -513 670 89 414 412 525 552 250 589
Total Pre-Tax Income 		176 126 -513 675 89 414 412 525 552 250 589
Total Revenue		 264 224 -380 810 212 541 542 697 645 344 644
Net Interest Income / (Expense)		 265 263 440 611 514 602 594 606 586 613 540
Total Interest Income		 761 773 773 938 1,030 1,361 1,273 1,139 934 873 688
Investment Securities Interest Income		 761 773 773 938 1,030 1,361 1,273 1,139 934 873 688
Total Interest Expense		 496 510 333 327 516 759 679 533 348 259 148
Long-Term Debt Interest Expense		 496 510 333 327 516 759 679 533 - 259 148
Total Non-Interest Income		 -0.73 -39 -820 199 -302 -61 -53 91 59 -270 104
Net Realized & Unrealized Capital Gains on Investments		 -3.44 -39 -820 199 -302 -61 -53 91 -27 -270 81
Investment Banking Income		 2.71 0.00 0.00 - - - - - - - -
Provision for Credit Losses		 9.84 11 7.04 0.03 - 0.00 0.00 - - - -0.23
Total Non-Interest Expense		 78 87 126 135 123 128 130 173 93 93 55
Salaries and Employee Benefits		 41 31 49 47 45 49 35 30 27 11 0.00
Other Operating Expenses		 36 56 77 89 78 74 73 81 66 83 55
Depreciation Expense		 0.32 0.00 0.00 - - - - - - - -
Income Tax Expense		 0.05 0.10 -0.25 4.41 0.16 0.19 0.09 0.00 0.08 0.00 0.00
Preferred Stock Dividends Declared		 86 74 74 74 74 73 43 33 2.45 0.00 0.00
Basic Earnings per Share		 $1.12 $0.68 ($7.53) $2.55 $0.07 $1.82 $1.97 $2.62 $2.93 $1.25 $2.87
Weighted Average Basic Shares Outstanding		 80.98M 76.69M 77.98M 233.77M 213.00M 187.16M 187.15M 187.78M 187.73M 199.56M 205.45M
Diluted Earnings per Share		 $1.10 $0.68 ($7.53) $2.44 $0.07 $1.81 $1.96 $2.61 $2.92 $1.25 $2.87
Weighted Average Diluted Shares Outstanding		 82.16M 77.54M 77.98M 245.50M 226.44M 188.41M 187.75M 188.29M 188.02M 199.65M 205.51M
Weighted Average Basic & Diluted Shares Outstanding		 80.92M 241.36M 231.83M 236.95M 230.56M 187.23M 187M 187.50M 187.50M 200.30M 205.30M
Cash Dividends to Common per Share		 $1.42 $2.10 - $1.29 $1.40 $2.00 $2.00 $2.00 $2.44 $1.92 $1.80

Quarterly Income Statements for Chimera Investment

This table shows Chimera Investment's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 3/31/2025 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Net Income / (Loss) Attributable to Common Shareholders		 146 -168 114 34 111 12 -16 18 39 79 -205
Consolidated Net Income / (Loss)		 167 -147 136 57 129 31 2.17 36 57 97 -186
Net Income / (Loss) Continuing Operations		 167 -147 136 57 129 31 2.17 36 57 97 -186
Total Pre-Tax Income 		169 -147 136 57 129 31 2.25 36 57 97 -186
Total Revenue		 207 -130 159 81 153 37 26 70 92 140 -162
Net Interest Income / (Expense)		 69 66 66 67 65 65 63 66 70 80 105
Total Interest Income		 191 192 195 187 187 191 196 197 189 187 188
Investment Securities Interest Income		 191 192 195 187 187 191 196 197 189 187 188
Total Interest Expense		 121 127 129 119 121 127 132 131 120 107 83
Long-Term Debt Interest Expense		 121 127 129 119 121 127 132 131 120 107 83
Total Non-Interest Income		 137 -196 93 14 88 -28 -37 4.15 22 60 -267
Net Realized & Unrealized Capital Gains on Investments		 128 -198 93 14 88 -28 -37 4.15 22 60 -267
Investment Banking Income		 8.94 - - - - - - - - - -
Provision for Credit Losses		 3.39 4.45 0.36 3.68 1.35 2.33 3.22 2.76 3.06 - -1.53
Total Non-Interest Expense		 34 12 22 21 23 3.64 21 31 31 39 26
Salaries and Employee Benefits		 13 18 7.20 7.01 9.21 5.28 7.12 7.68 10 19 10
Other Operating Expenses		 20 -6.15 15 14 13 -1.64 14 23 21 20 16
Depreciation Expense		 0.95 - - - - - - - - - -
Income Tax Expense		 1.76 -0.01 0.02 0.03 0.01 0.00 0.08 0.03 0.00 -0.28 0.00
Preferred Stock Dividends Declared		 21 22 23 23 18 18 18 18 18 18 18
Basic Earnings per Share		 $1.79 ($2.08) $1.41 $0.42 $0.46 $0.16 ($0.22) $0.23 $0.17 $1.01 ($0.88)
Weighted Average Basic Shares Outstanding		 81.35M 80.98M 80.81M 81.33M 243.72M 76.69M 75.58M 77.21M 231.99M 77.98M 231.75M
Diluted Earnings per Share		 $1.77 ($2.08) $1.39 $0.41 $0.45 $0.16 ($0.22) $0.23 $0.17 $1.01 ($0.88)
Weighted Average Diluted Shares Outstanding		 82.39M 82.16M 81.86M 82.28M 245.15M 77.54M 75.58M 77.96M 235.20M 77.98M 231.75M
Weighted Average Basic & Diluted Shares Outstanding		 80.97M 80.92M 80.88M 80.53M 241.42M 241.36M 226.76M 226.75M 232.10M 231.83M 231.75M
Cash Dividends to Common per Share		 $0.37 $0.64 $0.37 $0.35 $0.11 $0.56 $0.54 $0.54 $0.23 $0.92 $0.23

Annual Cash Flow Statements for Chimera Investment

This table details how cash moves in and out of Chimera Investment's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Net Change in Cash & Equivalents		 -138 -43 -121 117 159 62 -16 -114 64 -51 87
Net Cash From Operating Activities		 206 213 326 519 258 65 298 487 553 396 183
Net Cash From Continuing Operating Activities		 206 213 326 519 258 65 298 487 553 396 183
Net Income / (Loss) Continuing Operations		 176 126 -513 670 89 414 412 525 552 250 589
Consolidated Net Income / (Loss)		 176 126 -513 670 89 414 412 525 552 250 589
Provision For Loan Losses		 9.87 11 7.04 0.03 0.18 0.00 0.00 - - - -0.23
Depreciation Expense		 0.32 0.00 0.00 - - - - - - - -
Amortization Expense		 19 48 61 79 63 29 16 -18 -1.58 21 -61
Non-Cash Adjustments to Reconcile Net Income		 17 -13 822 -193 -198 -317 103 -61 -61 76 -168
Changes in Operating Assets and Liabilities, net		 -16 40 -51 -38 304 -61 -233 42 63 49 -177
Net Cash From Investing Activities		 178 552 510 2,548 8,330 1,237 -6,026 -4,331 -1,271 2,038 -5,779
Net Cash From Continuing Investing Activities		 178 552 510 2,548 8,330 1,237 -6,026 -4,331 -1,271 2,038 -5,779
Purchase of Investment Securities		 -1,852 -1,266 -2,148 -3,080 -3,025 -7,670 -9,722 -7,860 -6,141 -7,833 -10,000
Sale and/or Maturity of Investments		 2,031 1,818 2,658 5,628 11,355 8,906 3,696 3,529 4,871 9,868 4,221
Net Cash From Financing Activities		 -522 -808 -957 -2,951 -8,429 -1,240 5,712 3,730 781 -2,485 5,683
Net Cash From Continuing Financing Activities		 -522 -808 -957 -2,951 -8,429 -1,240 5,712 3,730 781 -2,485 5,683
Issuance of Debt		 474 2,186 1,123 5,522 3,404 1,487 1,770 5,152 4,797 1,483 44
Issuance of Common Equity		 0.00 74 0.00 0.00 - - - - - - 0.00
Repayment of Debt		 -1,171 -1,767 -1,847 -6,462 -2,553 -1,870 -2,657 -2,975 -1,863 -2,321 -583
Repurchase of Common Equity		 0.00 -33 -49 -1.83 -22 0.00 -15 0.00 0.00 -250 0.00
Payment of Dividends		 -223 -251 -362 -372 -396 -447 -418 -412 -454 -381 -575
Other Financing Activities, Net		 398 -1,017 178 -1,636 -8,862 -604 6,781 1,650 -1,838 -1,016 6,797
Cash Interest Paid		 479 470 323 339 578 835 644 512 335 237 111
Cash Interest Received		 761 774 842 1,020 1,168 1,427 1,279 1,092 917 881 577
Cash Income Taxes Paid		 0.05 0.10 -0.25 4.41 0.16 0.19 - - - - -

Quarterly Cash Flow Statements for Chimera Investment

This table details how cash moves in and out of Chimera Investment's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 3/31/2025 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Net Change in Cash & Equivalents		 169 -13 -65 -6.65 -53 83 -62 -31 -32 178 -72
Net Cash From Operating Activities		 49 38 41 69 57 31 45 107 30 26 41
Net Cash From Continuing Operating Activities		 49 38 41 69 57 31 45 107 30 26 41
Net Income / (Loss) Continuing Operations		 167 -147 136 57 129 31 2.17 36 57 97 -186
Consolidated Net Income / (Loss)		 167 -147 136 57 129 31 2.17 36 57 97 -186
Provision For Loan Losses		 3.39 4.48 0.36 3.69 1.35 2.33 3.22 2.76 3.06 3.83 -1.53
Depreciation Expense		 0.95 - - - - - - - - - -
Amortization Expense		 -0.03 -2.42 -1.96 13 9.70 3.95 14 20 11 -4.60 14
Non-Cash Adjustments to Reconcile Net Income		 -120 192 -88 -4.44 -83 19 44 -8.12 -68 -57 269
Changes in Operating Assets and Liabilities, net		 -2.76 -9.58 -5.74 -0.25 -0.51 -25 -19 57 28 -13 -55
Net Cash From Investing Activities		 -175 690 -646 -114 248 377 368 -111 -82 -146 486
Net Cash From Continuing Investing Activities		 -175 690 -646 -114 248 377 368 -111 -82 -146 486
Purchase of Investment Securities		 -553 -247 -1,033 -461 -111 -0.08 -36 -639 -591 -623 -67
Sale and/or Maturity of Investments		 378 937 387 347 360 377 404 528 509 478 554
Net Cash From Financing Activities		 296 -741 540 38 -358 -325 -475 -27 19 298 -599
Net Cash From Continuing Financing Activities		 296 -741 540 38 -358 -325 -475 -27 19 298 -599
Issuance of Debt		 780 -0.00 412 62 0.00 139 - 1,103 944 94 274
Repayment of Debt		 -597 -296 -307 -295 -273 -305 -324 -528 -609 -346 -445
Payment of Dividends		 -52 -52 -80 -46 -45 -43 -62 -72 -73 -72 -96
Other Financing Activities, Net		 164 -393 515 316 -40 -190 -81 -504 -242 621 -328
Cash Interest Paid		 122 122 124 114 120 119 125 115 112 99 81
Cash Interest Received		 185 182 182 209 188 186 199 207 181 188 204

Annual Balance Sheets for Chimera Investment

This table presents Chimera Investment's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Total Assets		 13,116 12,929 13,402 15,407 17,523 27,119 27,709 21,222 16,685 15,345 19,155
Cash and Due from Banks		 84 222 265 386 269 110 47 64 178 114 165
Trading Account Securities		 12,780 102 12,942 0.00 1,831 3.61 2,524 7,265 16,261 11,299 16,549
Loans and Leases, Net of Allowance		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 626
Other Assets		 252 1,208 196 2,760 2,311 12,712 12,565 215 246 3,932 1,816
Total Liabilities & Shareholders' Equity		 13,116 12,929 13,402 15,407 17,523 27,119 27,709 21,222 16,685 15,345 19,155
Total Liabilities		 10,590 10,370 10,735 11,671 13,744 23,165 24,005 17,587 13,561 12,398 15,547
Short-Term Debt		 2,824 2,432 3,435 3,262 4,637 13,428 14,030 7,250 5,603 7,449 8,470
Accrued Interest Payable		 41 38 31 20 41 64 110 62 49 37 32
Other Short-Term Payables		 34 - 65 - - - - - 97 - 92
Long-Term Debt		 7,190 7,677 7,179 7,814 8,877 8,313 8,615 9,594 7,275 4,250 5,095
Other Long-Term Liabilities		 500 223 26 575 189 1,361 1,249 680 537 662 1,858
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 2,526 2,559 2,667 3,736 3,779 3,953 3,704 3,635 3,124 2,946 3,608
Total Preferred & Common Equity		 2,526 2,559 2,667 3,736 3,779 3,953 3,704 3,635 3,124 2,946 3,608
Preferred Stock		 0.37 0.37 0.37 0.37 0.37 0.37 0.29 0.19 0.06 0.00 -
Total Common Equity		 2,526 2,559 2,666 3,736 3,779 3,953 3,704 3,635 3,123 2,946 3,608
Common Stock		 4,391 4,371 4,321 4,361 4,540 4,278 4,074 3,829 3,511 3,368 3,616
Retained Earnings		 -2,025 -1,998 -1,884 -1,031 -1,319 -1,033 -997 -991 -1,105 -1,196 -1,055
Accumulated Other Comprehensive Income / (Loss)		 159 186 229 405 558 708 627 797 718 774 1,047

Quarterly Balance Sheets for Chimera Investment

This table presents Chimera Investment's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q3 2024 Q2 2024 Q1 2024 Q3 2023 Q2 2023 Q1 2023 Q3 2022
Period end date 3/31/2025 9/30/2024 6/30/2024 3/31/2024 9/30/2023 6/30/2023 3/31/2023 9/30/2022
Total Assets		 13,205 13,702 13,132 12,547 12,887 13,510 14,204 13,669
Cash and Due from Banks		 253 97 162 169 139 201 232 86
Trading Account Securities		 656 13,425 12,793 66 128 143 278 13,369
Loans and Leases, Net of Allowance		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Loans Held for Sale		 10,984 - - 11,075 11,427 11,930 12,382 -
Other Assets		 1,312 180 176 1,237 1,194 1,237 1,311 200
Total Liabilities & Shareholders' Equity		 13,205 13,702 13,132 12,547 12,887 13,510 14,204 13,669
Total Liabilities		 10,561 10,965 10,491 9,901 10,393 10,930 11,554 11,016
Short-Term Debt		 2,994 3,229 2,699 2,385 2,604 2,687 3,195 2,821
Accrued Interest Payable		 38 40 39 35 36 37 31 26
Long-Term Debt		 7,403 7,521 7,214 7,410 7,675 8,118 7,585 7,434
Other Long-Term Liabilities		 126 142 477 71 79 88 743 671
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 2,644 2,737 2,641 2,646 2,494 2,579 2,649 2,654
Total Preferred & Common Equity		 2,644 2,737 2,641 2,646 2,494 2,579 2,649 2,654
Preferred Stock		 0.37 0.37 0.37 0.37 0.37 0.37 0.37 0.37
Total Common Equity		 2,644 2,737 2,641 2,645 2,494 2,579 2,649 2,653
Common Stock		 4,395 4,380 4,376 4,374 4,294 4,292 4,323 4,317
Retained Earnings		 -1,909 -1,826 -1,910 -1,914 -1,981 -1,923 -1,899 -1,908
Accumulated Other Comprehensive Income / (Loss)		 158 184 174 185 181 211 225 244

Annual Metrics And Ratios for Chimera Investment

This table displays calculated financial ratios and metrics derived from Chimera Investment's official financial filings.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 17.78% 158.92% -146.95% 282.31% -60.85% -0.08% -22.34% 8.13% 87.65% -46.65% 55.23%
EBITDA Growth		 11.91% 138.57% -159.98% 395.52% -65.68% 3.74% -15.69% -7.94% 102.88% -48.63% 76.70%
EBIT Growth		 39.54% 124.59% -176.10% 656.26% -78.44% 0.49% -21.54% -4.94% 120.50% -57.51% 62.84%
NOPAT Growth		 39.62% 135.09% -153.62% 654.17% -78.51% 0.47% -21.56% -4.92% 120.47% -57.51% 62.46%
Net Income Growth		 39.62% 124.58% -176.56% 654.17% -78.51% 0.47% -21.54% -4.94% 120.47% -57.51% 62.46%
EPS Growth		 61.76% 124.58% -176.56% 3,385.71% -96.13% -7.65% -24.90% -10.62% 133.60% -56.45% 62.46%
Operating Cash Flow Growth		 -3.56% -34.52% -37.26% 101.31% 296.55% -78.15% -38.93% -11.87% 39.52% 116.82% -40.04%
Free Cash Flow Firm Growth		 -58.99% -36.93% -62.82% -62.88% 694.06% 119.59% -38.07% -391.07% -128.98% 127.81% -842.51%
Invested Capital Growth		 -1.00% -4.62% -10.34% -14.35% -32.70% -2.49% 28.66% 27.98% 9.27% -14.72% 160.44%
Revenue Q/Q Growth		 -41.03% -31.22% 19.60% -13.88% 6.80% 74.94% -32.81% 0.00% 0.00% 11.53% 0.83%
EBITDA Q/Q Growth		 -48.41% -28.85% 12.27% -14.91% 22.73% 108.83% -32.02% 4,917.46% 4,839.36% 108.90% -12.01%
EBIT Q/Q Growth		 -50.13% -38.57% 12.99% -16.18% 23.70% 129.09% -33.81% 0.00% 0.00% 77.64% -9.91%
NOPAT Q/Q Growth		 -50.14% -34.58% 13.47% -16.20% 23.52% 129.20% -33.84% 0.00% 0.00% 76.98% -10.05%
Net Income Q/Q Growth		 -50.14% -34.58% 13.41% -16.20% 23.52% 129.20% -33.83% 0.00% 0.00% 76.98% -10.05%
EPS Q/Q Growth		 -67.16% -34.58% 13.41% -20.78% 112.96% 206.78% -36.98% 0.00% 0.00% 73.61% -10.05%
Operating Cash Flow Q/Q Growth		 3.33% 2.35% -20.24% 6.53% -33.94% 119.30% -55.44% -18.54% 36.10% 40.86% -24.14%
Free Cash Flow Firm Q/Q Growth		 183.93% 124.79% -50.20% 27.82% -12.17% 139.51% -72.99% -2.97% 40.68% 179.22% -158.76%
Invested Capital Q/Q Growth		 -7.02% -0.82% 2.88% -5.52% -0.29% -4.61% 9.56% 1.02% -2.63% -2.87% 50.25%
Profitability Metrics		 - - - - - - - - - - -
EBITDA Margin		 73.93% 77.81% 0.00% 93.05% 71.79% 81.89% 78.87% 72.66% 85.33% 78.93% 81.97%
EBIT Margin		 66.72% 56.32% 0.00% 83.27% 42.10% 76.44% 76.01% 75.24% 85.58% 72.83% 91.44%
Profit (Net Income) Margin		 66.71% 56.27% 0.00% 82.73% 41.94% 76.41% 75.99% 75.23% 85.57% 72.83% 91.44%
Tax Burden Percent		 99.97% 99.92% 99.95% 99.35% 99.82% 99.95% 99.98% 99.98% 99.99% 100.00% 100.00%
Interest Burden Percent		 100.00% 100.00% 100.00% 100.00% 99.80% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate		 0.03% 0.08% 0.00% 0.65% 0.18% 0.05% 0.02% 0.00% 0.02% 0.00% 0.00%
Return on Invested Capital (ROIC)		 1.40% 0.97% 0.00% 4.17% 0.41% 1.59% 1.76% 2.88% 3.60% 1.57% 4.96%
ROIC Less NNEP Spread (ROIC-NNEP)		 1.40% 0.97% 0.00% 4.17% 0.41% 1.59% 1.76% 2.88% 3.60% 1.57% 4.96%
Return on Net Nonoperating Assets (RNNOA)		 5.53% 3.85% 0.00% 13.66% 1.88% 9.21% 9.46% 12.65% 14.58% 6.07% 12.02%
Return on Equity (ROE)		 6.92% 4.83% -16.03% 17.83% 2.30% 10.80% 11.22% 15.53% 18.19% 7.64% 16.98%
Cash Return on Invested Capital (CROIC)		 2.40% 5.70% 8.34% 19.63% 39.50% 4.11% -23.31% -21.67% -5.25% 17.46% -84.06%
Operating Return on Assets (OROA)		 1.35% 0.96% 0.00% 4.10% 0.40% 1.51% 1.68% 2.77% 3.45% 1.45% 4.52%
Return on Assets (ROA)		 1.35% 0.96% 0.00% 4.07% 0.40% 1.51% 1.68% 2.77% 3.45% 1.45% 4.52%
Return on Common Equity (ROCE)		 6.92% 4.83% -16.02% 17.83% 2.30% 10.80% 11.22% 15.53% 18.19% 7.64% 16.98%
Return on Equity Simple (ROE_SIMPLE)		 6.97% 4.93% -19.24% 17.94% 2.35% 10.46% 11.11% 14.43% 17.67% 8.50% 16.33%
Net Operating Profit after Tax (NOPAT)		 176 126 -359 670 89 414 412 525 552 250 589
NOPAT Margin		 66.71% 56.27% 0.00% 82.73% 41.94% 76.41% 75.99% 75.24% 85.57% 72.83% 91.44%
Net Nonoperating Expense Percent (NNEP)		 0.00% 0.00% 1.42% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
SG&A Expenses to Revenue		 15.67% 13.64% 0.00% 5.78% 21.15% 9.03% 6.48% 4.33% 4.17% 3.07% 0.00%
Operating Expenses to Revenue		 29.55% 38.61% 0.00% 16.73% 57.90% 23.56% 23.99% 24.76% 14.42% 27.17% 8.60%
Earnings before Interest and Taxes (EBIT)		 176 126 -513 675 89 414 412 525 552 250 589
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 195 174 -452 754 152 443 427 507 550 271 528
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 0.45 0.40 0.38 0.69 0.42 0.56 0.47 0.45 0.43 0.32 0.29
Price to Tangible Book Value (P/TBV)		 0.45 0.40 0.38 0.69 0.42 0.56 0.47 0.45 0.43 0.32 0.29
Price to Revenue (P/Rev)		 4.29 4.56 0.00 3.20 7.51 4.13 3.23 2.34 2.10 2.70 1.60
Price to Earnings (P/E)		 12.53 19.51 0.00 4.34 105.30 6.55 4.74 3.32 2.46 3.71 1.75
Dividend Yield		 10.14% 15.54% 25.60% 11.79% 20.57% 16.76% 21.40% 23.05% 33.84% 39.04% 55.68%
Earnings Yield		 7.98% 5.13% 0.00% 23.02% 0.95% 15.26% 21.08% 30.14% 40.60% 26.93% 57.02%
Enterprise Value to Invested Capital (EV/IC)		 0.88 0.86 0.86 0.90 0.86 0.93 0.92 0.90 0.88 0.85 0.84
Enterprise Value to Revenue (EV/Rev)		 41.92 48.68 0.00 16.40 70.02 44.09 44.95 26.40 21.79 36.41 22.40
Enterprise Value to EBITDA (EV/EBITDA)		 56.70 62.56 0.00 17.62 97.53 53.84 56.99 36.33 25.53 46.13 27.33
Enterprise Value to EBIT (EV/EBIT)		 62.82 86.44 0.00 19.69 166.33 57.68 59.13 35.08 25.46 49.99 24.50
Enterprise Value to NOPAT (EV/NOPAT)		 62.84 86.51 0.00 19.82 166.96 57.71 59.15 35.08 25.46 49.99 24.50
Enterprise Value to Operating Cash Flow (EV/OCF)		 53.79 51.15 34.89 25.58 57.52 366.94 81.81 37.78 25.42 31.58 78.97
Enterprise Value to Free Cash Flow (EV/FCFF)		 36.51 14.76 9.70 4.21 1.75 22.32 0.00 0.00 0.00 4.51 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 3.96 3.95 3.98 2.96 3.58 5.50 6.11 4.63 4.12 3.97 3.76
Long-Term Debt to Equity		 2.85 3.00 2.69 2.09 2.35 2.10 2.33 2.64 2.33 1.44 1.41
Financial Leverage		 3.96 3.97 3.39 3.27 4.56 5.80 5.38 4.40 4.05 3.85 2.42
Leverage Ratio		 5.12 5.04 4.50 4.38 5.77 7.16 6.67 5.61 5.28 5.26 3.76
Compound Leverage Factor		 5.12 5.04 4.50 4.38 5.76 7.16 6.67 5.61 5.28 5.26 3.76
Debt to Total Capital		 79.86% 79.80% 79.92% 74.78% 78.15% 84.61% 85.94% 82.25% 80.48% 79.88% 78.99%
Short-Term Debt to Total Capital		 22.52% 19.20% 25.86% 22.02% 26.81% 52.26% 53.25% 35.40% 35.02% 50.86% 49.32%
Long-Term Debt to Total Capital		 57.34% 60.60% 54.06% 52.76% 51.33% 32.35% 32.70% 46.85% 45.46% 29.02% 29.67%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 20.14% 20.20% 20.08% 25.22% 21.85% 15.38% 14.06% 17.75% 19.52% 20.12% 21.01%
Debt to EBITDA		 51.32 57.97 -23.48 14.69 88.84 49.05 53.01 33.24 23.40 43.12 25.68
Net Debt to EBITDA		 50.89 56.70 -22.89 14.18 87.07 48.80 52.89 33.12 23.07 42.70 25.37
Long-Term Debt to EBITDA		 36.85 44.03 -15.88 10.37 58.36 18.76 20.17 18.93 13.22 15.66 9.65
Debt to NOPAT		 56.88 80.16 -29.54 16.53 152.09 52.57 55.01 32.10 23.33 46.73 23.02
Net Debt to NOPAT		 56.40 78.41 -28.80 15.95 149.06 52.31 54.90 31.98 23.01 46.27 22.74
Long-Term Debt to NOPAT		 40.84 60.88 -19.98 11.66 99.90 20.10 20.93 18.28 13.18 16.98 8.65
Noncontrolling Interest Sharing Ratio		 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 303 739 1,172 3,151 8,490 1,069 -5,458 -3,953 -805 2,778 -9,990
Operating Cash Flow to CapEx		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow to Firm to Interest Expense		 0.61 1.45 3.52 9.65 16.45 1.41 -8.04 -7.42 -2.31 10.71 -67.60
Operating Cash Flow to Interest Expense		 0.41 0.42 0.98 1.59 0.50 0.09 0.44 0.91 1.59 1.53 1.24
Operating Cash Flow Less CapEx to Interest Expense		 0.41 0.42 0.98 1.59 0.50 0.09 0.44 0.91 1.59 1.53 1.24
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.02 0.02 0.00 0.05 0.01 0.02 0.02 0.04 0.04 0.02 0.05
Fixed Asset Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 12,541 12,668 13,281 14,812 17,293 25,694 26,350 20,480 16,002 14,645 17,173
Invested Capital Turnover		 0.02 0.02 0.00 0.05 0.01 0.02 0.02 0.04 0.04 0.02 0.05
Increase / (Decrease) in Invested Capital		 -127 -613 -1,531 -2,481 -8,401 -656 5,870 4,478 1,357 -2,527 10,579
Enterprise Value (EV)		 11,063 10,909 11,364 13,281 14,835 23,864 24,347 18,411 14,054 12,514 14,434
Market Capitalization		 1,132 1,021 1,014 2,591 1,590 2,233 1,748 1,630 1,354 930 1,033
Book Value per Share		 $31.23 $11.28 $11.51 $15.77 $16.17 $21.12 $19.80 $19.36 $16.64 $15.59 $3.51
Tangible Book Value per Share		 $31.23 $11.28 $11.51 $15.77 $16.17 $21.12 $19.80 $19.36 $16.64 $15.59 $3.51
Total Capital		 12,541 12,668 13,281 14,812 17,293 25,694 26,350 20,480 16,002 14,645 17,173
Total Debt		 10,015 10,109 10,614 11,076 13,514 21,741 22,646 16,845 12,878 11,699 13,565
Total Long-Term Debt		 7,190 7,677 7,179 7,814 8,877 8,313 8,615 9,594 7,275 4,250 5,095
Net Debt		 9,931 9,887 10,349 10,690 13,244 21,631 22,598 16,781 12,701 11,585 13,400
Capital Expenditures (CapEx)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Nonoperating Expense (NNE)		 0.00 0.00 154 0.00 0.00 0.00 0.00 0.11 0.00 0.00 0.00
Net Nonoperating Obligations (NNO)		 10,015 10,109 10,614 11,076 13,514 21,741 22,646 16,845 12,878 11,699 13,565
Total Depreciation and Amortization (D&A)		 19 48 61 79 63 29 16 -18 -1.58 21 -61
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $1.12 $0.69 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic Shares Outstanding		 80.98M 76.69M 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Adjusted Diluted Earnings per Share		 $1.10 $0.69 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Diluted Shares Outstanding		 82.16M 77.54M 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 80.92M 80.45M 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Normalized Net Operating Profit after Tax (NOPAT)		 176 126 -359 670 89 418 433 411 552 175 412
Normalized NOPAT Margin		 66.71% 56.27% 0.00% 82.73% 41.94% 77.30% 80.01% 58.88% 85.57% 50.98% 64.01%
Pre Tax Income Margin		 66.72% 56.32% 0.00% 83.27% 42.01% 76.44% 76.01% 75.24% 85.58% 72.83% 91.44%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.35 0.25 -1.54 2.07 0.17 0.55 0.61 0.99 1.59 0.97 3.99
NOPAT to Interest Expense		 0.35 0.25 -1.08 2.05 0.17 0.55 0.61 0.99 1.59 0.97 3.99
EBIT Less CapEx to Interest Expense		 0.35 0.25 -1.54 2.07 0.17 0.55 0.61 0.99 1.59 0.97 3.99
NOPAT Less CapEx to Interest Expense		 0.35 0.25 -1.08 2.05 0.17 0.55 0.61 0.99 1.59 0.97 3.99
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 126.80% 198.67% -70.46% 55.57% 446.10% 108.08% 101.45% 78.47% 82.30% 152.26% 97.64%
Augmented Payout Ratio		 126.80% 224.92% -79.99% 55.85% 470.93% 108.08% 105.05% 78.47% 82.30% 252.12% 97.64%

Quarterly Metrics And Ratios for Chimera Investment

This table displays calculated financial ratios and metrics derived from Chimera Investment's official financial filings.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 3/31/2025 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 34.55% -455.94% 507.03% 16.20% 67.69% -73.92% 116.20% 155.46% 139.37% 196.23% -144.61%
EBITDA Growth		 22.14% -531.74% 723.66% 26.11% 104.71% -64.12% 109.50% 141.80% 128.39% 273.04% -148.61%
EBIT Growth		 30.58% -579.66% 5,979.06% 57.27% 125.68% -69.68% 101.21% 122.36% 121.84% 492.94% -155.93%
NOPAT Growth		 29.23% -435.79% 6,188.43% 57.30% 125.66% -68.58% 101.67% 131.92% 131.18% 448.10% -139.31%
Net Income Growth		 29.23% -579.68% 6,188.43% 57.30% 125.66% -68.58% 101.17% 122.33% 121.83% 448.10% -156.16%
EPS Growth		 30.15% -1,400.00% 731.82% 78.26% 164.71% -68.58% 101.17% 122.33% 114.29% 0.00% -167.69%
Operating Cash Flow Growth		 -14.80% 21.14% -7.31% -35.37% 88.15% 18.51% 9.97% -12.97% -77.60% -75.77% -73.02%
Free Cash Flow Firm Growth		 -138.79% -96.21% -518.10% 65.02% -24.53% -60.48% -94.76% -67.91% 1.14% -34.84% 32.05%
Invested Capital Growth		 4.84% -1.00% 5.59% -6.20% -7.37% -4.62% -1.05% -3.61% -9.60% -10.34% -17.66%
Revenue Q/Q Growth		 258.90% -181.58% 96.33% -47.13% 162.02% 39.14% -62.42% -23.71% -33.79% 186.42% -28.67%
EBITDA Q/Q Growth		 214.12% -210.72% 91.97% -49.64% 303.38% 111.23% -70.61% -18.26% -29.30% 155.95% -29.28%
EBIT Q/Q Growth		 215.38% -207.36% 140.72% -56.21% 323.83% 1,260.62% -93.77% -37.16% -43.06% 154.13% -15.45%
NOPAT Q/Q Growth		 263.12% -175.16% 140.82% -56.23% 323.83% 1,307.56% -93.98% -37.20% -40.98% 174.60% -15.45%
Net Income Q/Q Growth		 214.19% -207.37% 140.82% -56.23% 323.83% 1,307.56% -93.98% -37.20% -40.98% 152.22% -15.38%
EPS Q/Q Growth		 185.10% -249.64% 239.02% -8.89% 800.00% 1,307.56% -93.98% -37.20% -50.00% 152.22% -15.79%
Operating Cash Flow Q/Q Growth		 28.58% -8.37% -40.00% 20.53% 82.83% -29.89% -58.17% 250.91% 15.15% -34.94% -66.90%
Free Cash Flow Firm Q/Q Growth		 -1,878.29% 104.23% -165.13% -20.76% 73.96% 365.69% -74.29% -63.76% -8.91% -38.27% 57.49%
Invested Capital Q/Q Growth		 3.99% -7.02% 7.43% 0.92% -1.80% -0.82% -4.57% -0.34% 1.12% 2.88% -7.04%
Profitability Metrics		 - - - - - - - - - - -
EBITDA Margin		 82.31% 0.00% 84.45% 86.36% 90.67% 94.48% 62.24% 79.58% 74.27% 68.68% 0.00%
EBIT Margin		 81.87% 0.00% 85.67% 69.88% 84.36% 83.66% 8.56% 51.63% 62.68% 71.97% 0.00%
Profit (Net Income) Margin		 81.01% 0.00% 85.66% 69.84% 84.35% 83.65% 8.27% 51.59% 62.68% 69.43% 0.00%
Tax Burden Percent		 98.96% 100.00% 99.99% 99.95% 99.99% 99.99% 96.66% 99.93% 100.00% 100.29% 100.00%
Interest Burden Percent		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 96.19% 100.00%
Effective Tax Rate		 1.04% 0.00% 0.01% 0.05% 0.01% 0.01% 3.34% 0.07% 0.00% -0.29% 0.00%
Return on Invested Capital (ROIC)		 2.02% 0.00% 2.92% 1.69% 1.98% 1.44% 0.21% 0.52% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)		 2.02% 0.00% 2.92% 1.69% 1.98% 1.44% 0.21% 0.52% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)		 7.69% 0.00% 11.74% 6.72% 7.68% 5.73% 0.84% 2.04% 0.00% 0.00% 0.00%
Return on Equity (ROE)		 9.71% 0.00% 14.66% 8.42% 9.66% 7.17% 1.05% 2.56% -6.45% -16.03% -18.23%
Cash Return on Invested Capital (CROIC)		 -3.04% 2.40% -2.75% 8.09% 9.19% 5.70% 2.56% 3.71% 9.13% 8.34% 16.46%
Operating Return on Assets (OROA)		 2.02% 0.00% 2.88% 1.65% 1.91% 1.42% 0.21% 0.52% 0.00% 0.00% 0.00%
Return on Assets (ROA)		 1.99% 0.00% 2.88% 1.65% 1.91% 1.42% 0.20% 0.52% 0.00% 0.00% 0.00%
Return on Common Equity (ROCE)		 9.71% 0.00% 14.66% 8.41% 9.66% 7.17% 1.05% 2.56% -6.44% -16.02% -18.22%
Return on Equity Simple (ROE_SIMPLE)		 8.09% 0.00% 12.90% 8.29% 7.49% 0.00% 7.73% 0.17% -7.28% 0.00% -22.33%
Net Operating Profit after Tax (NOPAT)		 167 -103 136 57 129 31 2.17 36 57 97 -130
NOPAT Margin		 81.01% 0.00% 85.66% 69.84% 84.35% 83.65% 8.27% 51.59% 62.68% 69.43% 0.00%
Net Nonoperating Expense Percent (NNEP)		 0.00% 0.44% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.51%
SG&A Expenses to Revenue		 6.34% 0.00% 4.52% 8.64% 6.00% 14.46% 27.15% 10.99% 11.46% 13.69% 0.00%
Operating Expenses to Revenue		 16.49% 0.00% 14.10% 25.58% 14.77% 9.96% 79.19% 44.42% 33.98% 28.03% 0.00%
Earnings before Interest and Taxes (EBIT)		 169 -147 136 57 129 31 2.25 36 57 101 -186
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 170 -149 135 70 139 34 16 56 68 96 -172
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 0.39 0.45 0.47 0.39 0.40 0.40 0.45 0.47 0.43 0.38 0.37
Price to Tangible Book Value (P/TBV)		 0.39 0.45 0.47 0.39 0.40 0.40 0.45 0.47 0.43 0.38 0.37
Price to Revenue (P/Rev)		 3.28 4.29 2.85 3.27 3.48 4.56 3.45 8.75 0.00 0.00 0.00
Price to Earnings (P/E)		 8.29 12.53 4.71 7.32 8.48 19.51 9.45 0.00 0.00 0.00 0.00
Dividend Yield		 11.38% 10.14% 8.72% 12.11% 16.00% 15.54% 16.54% 16.78% 20.76% 25.60% 29.11%
Earnings Yield		 12.06% 7.98% 21.24% 13.67% 11.79% 5.13% 10.58% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.86 0.88 0.88 0.86 0.86 0.86 0.88 0.88 0.87 0.86 0.86
Enterprise Value to Revenue (EV/Rev)		 35.28 41.92 26.65 34.28 35.23 48.68 34.57 85.82 0.00 0.00 0.00
Enterprise Value to EBITDA (EV/EBITDA)		 49.49 56.70 31.53 41.46 43.50 62.56 45.96 226.47 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 51.84 62.82 33.77 49.24 53.86 86.44 54.83 958.69 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 52.28 62.84 33.78 49.27 53.89 86.51 58.44 2,656.50 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 56.71 53.79 59.92 53.29 44.49 51.15 54.06 57.79 53.07 34.89 27.28
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 36.51 0.00 10.28 8.99 14.76 34.26 23.34 9.06 9.70 4.74
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 3.93 3.96 3.93 3.75 3.70 3.95 4.12 4.19 4.07 3.98 3.86
Long-Term Debt to Equity		 2.80 2.85 2.75 2.73 2.80 3.00 3.08 3.15 2.86 2.69 2.80
Financial Leverage		 3.82 3.96 4.02 3.97 3.89 3.97 3.99 3.91 3.73 3.39 3.40
Leverage Ratio		 4.87 5.12 5.08 5.10 5.05 5.04 5.16 4.96 4.92 4.50 4.56
Compound Leverage Factor		 4.87 5.12 5.08 5.10 5.05 5.04 5.16 4.96 4.92 4.33 4.56
Debt to Total Capital		 79.73% 79.86% 79.70% 78.96% 78.73% 79.80% 80.47% 80.73% 80.27% 79.92% 79.44%
Short-Term Debt to Total Capital		 22.96% 22.52% 23.94% 21.50% 19.17% 19.20% 20.39% 20.07% 23.79% 25.86% 21.85%
Long-Term Debt to Total Capital		 56.77% 57.34% 55.76% 57.46% 59.56% 60.60% 60.08% 60.66% 56.48% 54.06% 57.59%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 20.27% 20.14% 20.29% 21.04% 21.26% 20.20% 19.53% 19.27% 19.73% 20.08% 20.55%
Debt to EBITDA		 46.02 51.32 28.42 38.12 39.89 57.97 41.94 207.23 -80.09 -23.48 -19.90
Net Debt to EBITDA		 44.90 50.89 28.16 37.49 39.20 56.70 41.38 203.37 -78.36 -22.89 -19.73
Long-Term Debt to EBITDA		 32.76 36.85 19.88 27.74 30.18 44.03 31.32 155.70 -56.35 -15.88 -14.43
Debt to NOPAT		 48.61 56.88 30.44 45.30 49.42 80.16 53.32 2,430.82 -79.76 -29.54 -24.70
Net Debt to NOPAT		 47.42 56.40 30.17 44.56 48.57 78.41 52.60 2,385.61 -78.04 -28.80 -24.49
Long-Term Debt to NOPAT		 34.61 40.84 21.30 32.96 37.39 60.88 39.81 1,826.43 -56.12 -19.98 -17.90
Noncontrolling Interest Sharing Ratio		 0.01% 0.00% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01%
Liquidity Ratios		 - - - - - - - - - - -
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -434 24 -578 887 1,119 643 138 537 1,483 1,628 2,638
Operating Cash Flow to CapEx		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow to Firm to Interest Expense		 -3.58 0.19 -4.48 7.43 9.22 5.08 1.05 4.10 12.40 15.23 31.60
Operating Cash Flow to Interest Expense		 0.40 0.30 0.32 0.58 0.47 0.25 0.34 0.81 0.25 0.25 0.49
Operating Cash Flow Less CapEx to Interest Expense		 0.40 0.30 0.32 0.58 0.47 0.25 0.34 0.81 0.25 0.25 0.49
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.02 0.02 0.03 0.02 0.02 0.02 0.02 0.01 0.00 0.00 0.00
Fixed Asset Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 13,041 12,541 13,487 12,554 12,440 12,668 12,773 13,384 13,430 13,281 12,909
Invested Capital Turnover		 0.02 0.02 0.03 0.02 0.02 0.02 0.03 0.01 0.00 0.00 0.00
Increase / (Decrease) in Invested Capital		 601 -127 714 -830 -990 -613 -136 -501 -1,426 -1,531 -2,768
Enterprise Value (EV)		 11,182 11,063 11,928 10,781 10,681 10,909 11,264 11,808 11,688 11,364 11,141
Market Capitalization		 1,038 1,132 1,275 1,030 1,056 1,021 1,124 1,204 1,139 1,014 971
Book Value per Share		 $32.67 $31.23 $33.99 $10.94 $10.96 $11.28 $11.00 $11.11 $11.43 $11.51 $11.45
Tangible Book Value per Share		 $32.67 $31.23 $33.99 $10.94 $10.96 $11.28 $11.00 $11.11 $11.43 $11.51 $11.45
Total Capital		 13,041 12,541 13,487 12,554 12,440 12,668 12,773 13,384 13,430 13,281 12,909
Total Debt		 10,397 10,015 10,750 9,913 9,794 10,109 10,278 10,805 10,780 10,614 10,255
Total Long-Term Debt		 7,403 7,190 7,521 7,214 7,410 7,677 7,675 8,118 7,585 7,179 7,434
Net Debt		 10,144 9,931 10,652 9,751 9,625 9,887 10,140 10,604 10,548 10,349 10,169
Capital Expenditures (CapEx)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Nonoperating Expense (NNE)		 0.00 44 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 56
Net Nonoperating Obligations (NNO)		 10,397 10,015 10,750 9,913 9,794 10,109 10,278 10,805 10,780 10,614 10,255
Total Depreciation and Amortization (D&A)		 0.92 -2.42 -1.96 13 9.70 3.95 14 20 11 -4.60 14
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $1.79 ($2.08) $1.41 $0.42 $1.38 $0.48 ($0.21) $0.24 $0.51 $3.03 ($2.64)
Adjusted Weighted Average Basic Shares Outstanding		 81.35M 80.98M 80.81M 81.33M 81.24M 25.56M 75.58M 77.21M 77.33M 25.99M 77.25M
Adjusted Diluted Earnings per Share		 $1.77 ($2.08) $1.39 $0.41 $1.35 $0.48 ($0.21) $0.24 $0.51 $3.03 ($2.64)
Adjusted Weighted Average Diluted Shares Outstanding		 82.39M 82.16M 81.86M 82.28M 81.72M 25.85M 75.58M 77.96M 78.40M 25.99M 77.25M
Adjusted Basic & Diluted Earnings per Share		 $0.00 ($2.08) $0.00 $0.00 $0.00 $0.48 $0.00 $0.00 $0.00 $3.03 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 80.97M 80.92M 80.88M 80.53M 80.47M 80.45M 75.59M 75.58M 77.37M 77.28M 77.25M
Normalized Net Operating Profit after Tax (NOPAT)		 167 -103 136 57 129 31 2.17 36 40 68 -130
Normalized NOPAT Margin		 81.01% 0.00% 85.66% 69.84% 84.35% 83.65% 8.27% 51.59% 43.88% 48.46% 0.00%
Pre Tax Income Margin		 81.86% 0.00% 85.67% 69.88% 84.36% 83.66% 8.56% 51.63% 62.68% 69.23% 0.00%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 1.39 -1.16 1.06 0.47 1.07 0.24 0.02 0.27 0.48 0.94 -2.23
NOPAT to Interest Expense		 1.38 -0.81 1.06 0.47 1.07 0.24 0.02 0.27 0.48 0.91 -1.56
EBIT Less CapEx to Interest Expense		 1.39 -1.16 1.06 0.47 1.07 0.24 0.02 0.27 0.48 0.94 -2.23
NOPAT Less CapEx to Interest Expense		 1.38 -0.81 1.06 0.47 1.07 0.24 0.02 0.27 0.48 0.91 -1.56
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 107.50% 126.80% 60.64% 89.62% 112.27% 198.67% 145.15% 7,044.03% -175.31% -70.46% -65.21%
Augmented Payout Ratio		 107.50% 126.80% 60.64% 92.77% 112.27% 224.92% 162.32% 7,741.26% -175.31% -79.99% -73.46%

Frequently Asked Questions About Chimera Investment's Financials

When does Chimera Investment's fiscal year end?

According to the most recent income statement we have on file, Chimera Investment's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Chimera Investment's net income changed over the last 10 years?

Chimera Investment's net income appears to be on a downward trend, with a most recent value of $176.07 million in 2024, falling from $589.21 million in 2014. The previous period was $126.10 million in 2023. Find out what analysts predict for Chimera Investment in the coming months.

How has Chimera Investment revenue changed over the last 10 years?

Over the last 10 years, Chimera Investment's total revenue changed from $644.36 million in 2014 to $263.94 million in 2024, a change of -59.0%.

How much debt does Chimera Investment have?

Chimera Investment's total liabilities were at $10.59 billion at the end of 2024, a 2.1% increase from 2023, and a 31.9% decrease since 2014.

How much cash does Chimera Investment have?

In the past 10 years, Chimera Investment's cash and equivalents has ranged from $47.49 million in 2018 to $385.74 million in 2021, and is currently $84.00 million as of their latest financial filing in 2024.

How has Chimera Investment's book value per share changed over the last 10 years?

Over the last 10 years, Chimera Investment's book value per share changed from 3.51 in 2014 to 31.23 in 2024, a change of 789.5%.


Related Companies

This page (NYSE:CIM) was last updated on 5/23/2025 by MarketBeat.com Staff
From Our Partners
Market Panic: Trump Just Dropped a Bomb on Your Stocks
tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...
American Alternative | Sponsored
White House to reset Social Security?
Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...
Altimetry | Sponsored
Buffett’s favorite chart just hit 209% – here’s what that means for gold
A Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...
Golden Portfolio | Sponsored
Everyone’s watching Nvidia right now. Here’s why I’m excited.
So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...
Timothy Sykes | Sponsored
Is President Trump Lying To You With This?
President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...
Colonial Metals | Sponsored
July 2025 Rule Change to Impact Retirement Investors
There's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...
Premier Gold Co | Sponsored
Silver Is the New Oil—And the World’s Running Dry
Elon's Next Market Move Could Send Silver Soaring Every industry Elon Musk touches explodes—from Tesla to S...
Priority Gold | Sponsored
Trump’s Bitcoin Reserve is No Accident…
Bitcoin's supply is being drained at unprecedented rates, but while most investors focus solely on Bitcoin, th...
Crypto 101 Media | Sponsored